Global Interventional Neurology Market Global Analysis, Size, Share, Trends, And Forecast 2018– 2026

Global Interventional Neurology
Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Global Interventional Neurology Market – Overview
Tissue plasminogen activators (tPAs) are used for treatment of stroke, aneurysms, stenosis, and vascular malformations. A study
published in the New England Journal of Medicine stated that Neurointerventional surgery in addition to IV-administered "clotbusting" tissue plasminogen activator (IV-tPA) therapy is more effective than administering IV-tPA alone for the treatment of
stroke.
According to the Brain Aneurysm Foundation (BAF), brain aneurysm accounts for around 500,000 deaths each year. BAF
estimates that aneurysm is predominant in the age group of 35–60 years. Moreover, globally around 15 million people suffer a
stroke every year, as per stats released by the World Heart Federation. High incidence of stroke and brain aneurysm is contributing
to increasing demand for interventional neurology devices. Furthermore, introduction of new techniques such as flow diverter and
aspiration are propelling demand for interventional neurology devices. The global Interventional neurology market was valued at
US$ 1,694.5 million in 2015 and is expected to expand at a CAGR of 5.3% during the forecast period (2016 – 2024).
Coiling is the conventional and more of a gold standard treatment technique for stroke. Increasing complexities in treating patients
suffering from recurring stroke incidents is driving demand for advanced technological products. Neurointerventional devices such
as Intrasaccular devices, stent retrievers, and flow diverters are expected to gain major traction during the forecast period (2016 –
2024). Intrasaccular devices are expected to be launched in the U.S. and Japan market by 2018. Realizing the benefits of stent
retrievers, the American Heart Association and American Stroke Association have issued guidelines, recommending the use of stent
retrievers along with tPA for treatment of stroke.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Global Interventional Neurology Market Taxonomy:
By Product Type:
●
Embolic coils
●
Carotid stents
●
Intracranial stents
By Technique:
●
Neurothrombectomy Procedure
●
Cerebral Angiography Technique
●
Stenting Technique
●
Coiling Procedure Technique
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/56
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Global Interventional Neurology Market: Key Players
●
Medtronic, Inc. (Covidien)
●
Penumbra, Inc.
●
Stryker Corporation.
●
Johnson & Johnson.
●
Terumo Corporation.
View this report @
https://www.coherentmarketinsights.com/market-insight/interventional-neurology-market-56
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us , v is it o ur w eb site:
w ww.coh er en tmark etins ig hts.com
THANK YOU
© Coherent market Insights. All Rights Reserved
F or s ales q ueries o r new top ics email u s o n :
s ales@coh er en tmark etins ig hts .co m
Fo r o th er q uer ies co n tact:
Mr. Sh ah
( Man ag er - Bus iness D ev elo pment)
Co herent Mark et Ins ig hts
s ales@coh er en tmark etins ig hts .co m
+1 -2 06 -7 0 1- 67 02

Neurovascular conditions such as stroke and aneurysms are generally treated with tissue plasminogen activators (tPAs). However, use of neurointerventional devices along with the medication therapy is more effective in removing clots and reducing the risk of early recurrence of the condition.